CEO Granted Substantial Performance Share Units Tied to Key FDA Milestones
DBVT has more than doubled off its 52-week low of $7.526.
Summary
DBV Technologies' CEO, Daniel Tassé, was granted 1.74 million performance share units (PSUs) with vesting contingent on FDA acceptance of Biologics License Applications for Viaskin Peanut in two age groups.
Key Events · Executive and Board Changes · DBVT
-
CEO Performance Share Grant
Daniel Tassé, CEO, was granted 1,740,000 Performance Share Units (PSUs) on May 5, 2026.
-
FDA Milestone Vesting
Vesting of PSUs is contingent on FDA acceptance for review of Biologics License Applications (BLAs) for Viaskin Peanut in patients aged 4-7 years and 1-3 years. Each condition accounts for 50% of the PSUs.
-
Long-Term Incentive
The PSUs are subject to continued employment through July 1, 2028, with vested shares delivered in installments through January 2030, aligning CEO compensation with long-term company performance and regulatory success.
-
Significant Potential Value
If fully vested, these PSUs represent a substantial potential compensation package for the CEO, underscoring the importance of the regulatory milestones for the company's flagship product.
Analysis · DBVT · Life Sciences
This significant performance-based compensation package for the CEO directly aligns his incentives with the successful regulatory progression of Viaskin Peanut, the company's lead product. The vesting of these PSUs is entirely dependent on achieving critical FDA acceptance milestones for both the 4-7 and 1-3 year age groups by July 2028. This structure signals strong management confidence in the product's potential and a clear focus on advancing it through the regulatory process, which is crucial for the company's future value creation following recent positive Phase 3 results and financing.
At the time of this filing, DBVT was trading at $19.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $7.53 to $26.19. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.